Cubist Systematic Strategies, LLC Danaher Corp Call Options Transaction History

Cubist Systematic Strategies, LLC

6 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q1 2024 May 15, 2024	SELL	$224.58 - $256.19 $5.12 Million - $5.84 Million	-22,800 Reduced 86.36%	3,600 $898,000
Q4 2023 Feb 14, 2024	SELL	$185.1 - $233.13 $74,040 - $93,252	-400 Reduced 1.49%	26,400 $6.11 Million
Q3 2023 Nov 14, 2023	SELL	$233.08 - $265.59 $3.64 Million - $4.14 Million	-15,600 Reduced 36.79%	26,800 $6.65 Million
Q2 2023 Aug 14, 2023	BUY	$224.99 - $256.14 $8.82 Million - $10 Million	39,200 Added 1225.0%	42,400 $10.2 Million
Q1 2023 May 15, 2023	BUY	$239.75 - $277.0 $767,200 - $886,400	3,200 New	3,200 $806,000
Q2 2022 Aug 15, 2022	BUY	$237.11 - $299.66 $6.05 Million - $7.64 Million	25,500 New	25,500 $6.47 Million

2,510

542M

7.07M

4.55M

Ticker DHR
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 727,963,008
Market Cap $172B
Description
Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company operates through three segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment provides mass spectrometers; flow cytometry, genomics, lab automati...

Get notified when there are updates to the investment portfolio of Cubist Systematic Strategies, LLC, based on Form 13F filings with the SEC.

Stay updated on Cubist Systematic Strategies, LLC with notifications on news.